Baker Bros. Advisors LP Insider Trading Activity

Institutional FilerDirector · CIK 1263508

84

Total trades

$335.5M

Total volume

Dec 18, 2025

Last activity

MDGL

MADRIGAL PHARMACEUTICALS, INC.

Baker Bros. Advisors LP, an institutional filer, recorded 82 transactions over the last 12 months across 6 companies totaling $306.7M.

Activity concentrated in MDGL with 54 filings. The largest single transaction was a purchase of KYMR for $158.1M on Dec 11, 2025.

Performance Scorecard

Forward stock performance after each transaction by Baker Bros. Advisors LP. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.

PERIODAVG BUY RETURNAVG SELL AVOIDEDSUCCESS RATETRADES
30 days+16.6%-2493.0%88%84
90 days+45.2%-1833.4%90%84
120 days+52.5%-1783.4%93%84

Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.

Price & Trades

Pro: Trade Markers

🔒 Subscribe to see trade entries

Pro members see exactly when Baker Bros. Advisors LP bought and sold MDGL.

Upgrade to Pro

Recent Trades

Showing the 50 most recent of 84 disclosed trades.

DATETICKERTYPESHARESPRICEVALUEΔ OWNEDROLEFILING
Dec 18, 2025
KODBuy217,428$23.00$5.0M+16.2%Director
Dec 18, 2025
KODBuy2,391,268$23.00$55.0M+15.0%Director
Dec 11, 2025
KYMRBuy167,192$86.00$14.4M+31.3%Director
Dec 11, 2025
KYMRBuy1,838,621$86.00$158.1M+30.1%Director
Nov 20, 2025
TRDABuy1,186$9.07$11K+0.3%10%+ Owner
Nov 20, 2025
TRDABuy1,213$9.07$11K+0.3%10%+ Owner
Nov 20, 2025
TRDABuy13,386$9.07$121K+0.3%10%+ Owner
Nov 20, 2025
TRDABuy13,082$9.07$119K+0.3%10%+ Owner
Nov 12, 2025
TRDABuy11,494$7.95$91K+0.2%10%+ Owner
Nov 12, 2025
TRDABuy1,040$7.95$8K+0.3%10%+ Owner
Nov 12, 2025
TRDABuy80,881$7.73$625K+1.8%10%+ Owner
Nov 12, 2025
TRDABuy7,321$7.73$57K+2.0%10%+ Owner
Nov 11, 2025
TRDABuy2,795$7.54$21K+0.8%10%+ Owner
Nov 11, 2025
TRDABuy1,059$7.39$8K+0.3%10%+ Owner
Nov 11, 2025
TRDABuy11,701$7.39$86K+0.3%10%+ Owner
Nov 11, 2025
TRDABuy30,879$7.54$233K+0.7%10%+ Owner
Nov 10, 2025
TRDABuy2,947$7.22$21K+0.1%10%+ Owner
Nov 10, 2025
TRDABuy267$7.22$2K+0.1%10%+ Owner
Nov 10, 2025
TRDABuy25,364$7.21$183K+0.6%10%+ Owner
Nov 10, 2025
TRDABuy2,296$7.21$17K+0.6%10%+ Owner
Oct 1, 2025
KALASell50,640$1.38$70K−52.1%Other
Oct 1, 2025
KALASell462,967$1.38$641K−52.1%Other
Sep 30, 2025
KALASell21,376$1.60$34K−18.0%Other
Sep 30, 2025
KALASell195,425$1.60$312K−18.0%Other
Sep 8, 2025
CELCBuy4,212$58.02$244K+0.1%10%+ Owner
Sep 8, 2025
CELCBuy13,976$56.22$786K+2.0%10%+ Owner
Sep 8, 2025
CELCBuy151,524$56.22$8.5M+2.1%10%+ Owner
Sep 8, 2025
CELCBuy388$58.02$23K+0.1%10%+ Owner
Aug 20, 2025
MDGLBuy1,919$380.78$731K+0.1%Director
Aug 20, 2025
MDGLBuy480$380.44$183K+0.2%Director
Aug 20, 2025
MDGLBuy5,209$380.44$2.0M+0.3%Director
Aug 20, 2025
MDGLBuy176$380.78$67K+0.1%Director
Aug 20, 2025
MDGLBuy873$381.12$333K+0.4%Director
Aug 20, 2025
MDGLBuy9,477$381.12$3.6M+0.5%Director
Aug 20, 2025
MDGLBuy105$382.29$40K+0.1%Director
Aug 20, 2025
MDGLBuy1,136$382.29$434K+0.1%Director
Aug 20, 2025
MDGLBuy262$382.82$100K+0.1%Director
Aug 20, 2025
MDGLBuy2,838$382.82$1.1M+0.1%Director
Aug 20, 2025
MDGLBuy373$383.79$143K+0.2%Director
Aug 20, 2025
MDGLBuy4,049$383.79$1.6M+0.2%Director
Aug 20, 2025
MDGLBuy1,248$385.06$481K+0.6%Director
Aug 20, 2025
MDGLBuy13,545$385.06$5.2M+0.7%Director
Aug 20, 2025
MDGLBuy409$387.07$158K+0.2%Director
Aug 20, 2025
MDGLBuy4,441$387.07$1.7M+0.2%Director
Aug 20, 2025
MDGLBuy34$389.00$13K+0.0%Director
Aug 20, 2025
MDGLBuy366$389.00$142K+0.0%Director
Aug 20, 2025
MDGLBuy231$389.89$90K+0.1%Director
Aug 20, 2025
MDGLBuy2,506$389.89$977K+0.1%Director
Aug 20, 2025
MDGLBuy862$392.24$338K+0.4%Director
Aug 20, 2025
MDGLBuy9,362$392.24$3.7M+0.5%Director

Top Companies Traded

TICKERCOMPANYTRADESTOTAL VOLUME
MDGLMADRIGAL PHARMACEUTICALS, INC.54$61.9M
TRDAEntrada Therapeutics, Inc.16$1.6M
CELCCelcuity Inc.4$9.6M
KALAKALA BIO, Inc.4$1.1M
KYMRKymera Therapeutics, Inc.4$201.3M
KODKodiak Sciences Inc.2$60.0M

Other insiders at MADRIGAL PHARMACEUTICALS, INC.

8 other tracked filers at MDGL.